Body Mass Index divides weight (kg) by height (m) squared. It was invented in the 1830s by a mathematician (not a physician) as a statistical tool for studying populations. It was never designed to assess individual health.

BMI fails in both directions:

False negatives: "Normal weight" people with high body fat percentage, visceral fat, and metabolic dysfunction — called TOFI (Thin Outside, Fat Inside) or "metabolically obese normal weight." Studies estimate 20-30% of normal-BMI adults are metabolically unhealthy. These people pass every weight screening but have the same cardiovascular and diabetes risk as someone with obesity.

False positives: Muscular individuals with low body fat and excellent metabolic health who are classified as "overweight" or "obese" by BMI alone. A 200lb person at 12% body fat and a 200lb person at 35% body fat get the same BMI.

BMI tells you about mass. It tells you nothing about composition (fat vs. muscle), distribution (subcutaneous vs. visceral), or metabolic function (insulin sensitivity, inflammation, hormone levels). It's a screening heuristic for large populations, not a diagnosis for individuals.

Metabolic syndrome is defined by having 3 or more of these 5 markers in the abnormal range. But even having 1-2 is a signal worth addressing:

1. Waist Circumference: Above 40 inches (men) or 35 inches (women). Waist circumference is a better predictor of metabolic risk than BMI because it reflects visceral fat — the metabolically active fat around your organs that produces inflammatory cytokines.

2. Triglycerides: Above 150 mg/dL fasting. Elevated triglycerides signal that your body is struggling to process carbohydrates and fats efficiently. Often the first lipid marker to go abnormal with insulin resistance.

3. HDL Cholesterol: Below 40 mg/dL (men) or 50 mg/dL (women). Low HDL reflects impaired reverse cholesterol transport and is independently associated with cardiovascular risk.

4. Blood Pressure: Above 130/85 mmHg. Elevated blood pressure damages arterial walls over time and is both a cause and consequence of metabolic dysfunction.

5. Fasting Glucose: Above 100 mg/dL. As we covered in Blood Work Literacy, this is one of the LAST markers to go abnormal — by the time glucose is elevated, insulin resistance has been developing for years.

The 2018 UNC Chapel Hill study found that only 12.2% of American adults are metabolically healthy by ALL five markers. That means 87.8% of Americans have at least one metabolic abnormality — and most don't know it because they've never been evaluated as a system.

Not all body fat is equal. Subcutaneous fat (under the skin — the fat you can pinch) is relatively metabolically inert. It's an energy storage depot. Visceral fat (around your organs — liver, pancreas, intestines) is metabolically active tissue that functions almost like an endocrine organ.

Visceral fat actively produces: - Inflammatory cytokines (IL-6, TNF-alpha) that drive systemic inflammation - Resistin (promotes insulin resistance) - Free fatty acids that overwhelm the liver (contributing to non-alcoholic fatty liver disease) - Angiotensinogen (raises blood pressure)

This is why two people at the same weight can have dramatically different health profiles. A person carrying fat primarily subcutaneously (pear-shaped distribution) has lower metabolic risk than someone carrying fat viscerally (apple-shaped distribution).

Waist circumference is the simplest proxy for visceral fat. The waist-to-hip ratio is more specific: above 0.90 (men) or 0.85 (women) indicates visceral fat accumulation. A DEXA scan can measure visceral fat directly.

The good news: visceral fat is the FIRST fat to respond to intervention. When you improve your diet, start exercising, or reduce stress, visceral fat mobilizes before subcutaneous fat. This is why metabolic markers often improve before the scale changes — the most dangerous fat is leaving first.

If metabolic syndrome is a tree, insulin resistance is the root system. Most of the 5 metabolic markers are downstream consequences of insulin resistance:

Insulin resistance → the pancreas overproduces insulin → chronically elevated insulin promotes triglyceride production → triglycerides rise. Elevated insulin promotes sodium retention → blood pressure rises. Insulin resistance impairs HDL metabolism → HDL drops. Visceral fat accumulation accelerates → waist circumference increases. Eventually, the pancreas can't keep up → glucose rises.

The cascade is predictable. And it's reversible at every stage — but the earlier you intervene, the easier it is.

What drives insulin resistance? The primary drivers are: chronically excessive carbohydrate intake (especially refined carbs and sugar), sedentary behavior (muscle is the primary glucose disposal tissue — unused muscle becomes insulin resistant), chronic sleep deprivation (one week of 4-5 hour sleep induces measurable insulin resistance in healthy young adults), chronic stress (cortisol directly impairs insulin signaling), and visceral fat accumulation (creates a self-reinforcing cycle).

What reverses it? In order of evidence and effect size: resistance training (builds glucose-disposing muscle tissue), walking after meals (clears glucose using existing muscle), reducing refined carbohydrates, time-restricted eating (gives insulin time to return to baseline), adequate sleep (7-9 hours), stress management, and specific supplements (berberine, magnesium, chromium — but lifestyle is 90% of the solution).